Biblio Discovery — Demo Discovery Service

59 hasil

Menampilkan 1–20 · 0,13 detik · RSS

Jurnal

Precision Medication

ISSN 2950-5232 · KeAi Communications Co., Ltd. · 59 artikel di indeks

  1. Artikel Jurnal

    Interpretation of the World Health Organization guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults

    Tianyi Ma; Luping Ren

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    The World Health Organization (WHO) issued the Guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults in 2025 to address the growing global burden of obesity, a chronic, progressive, and highly recurrent disease that has long been inadequately managed as a…

  2. Artikel Jurnal

    Comparison of the efficacy of nemonoxacin and moxifloxacin in the treatment of elderly patients with COPD complicated by acute lower respiratory tract infection

    Ying Cai; Shu Cao; Yong Li

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Objective: To evaluate the efficacy of nemonoxacin versus moxifloxacin in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD) complicated by acute lower respiratory tract infection. Methods: A total of 105 elderly patients with COPD complicated by acute lower…

  3. Artikel Jurnal

    Efficacy and safety of nemonoxacin injection in the treatment of community-acquired pneumonia in adults and its effect on serum inflammatory factors

    Jingyu Wang; Zihui Wen; Xiaoying Li dkk.

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Objective: To investigate the efficacy and safety of nemonoxacin injection in the treatment of community-acquired pneumonia (CAP) in adults, as well as its effect on serum inflammatory factors. Methods: A total of 103 adult CAP patients who were admitted to our hospital from April 2024 to May 2025…

  4. Artikel Jurnal

    Research advances in established risk factors for community-acquired pneumonia

    Feng Gu

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Community-acquired pneumonia (CAP) remains an important cause of morbidity and mortality, with its risk factors varying across age groups, pathogen profiles, and individual clinical characteristics. This review summarizes recent advances in established risk factors for CAP, with particular…

  5. Artikel Jurnal

    Translating localized renal reprogramming to systemic protection: A comprehensive review of SGLT2 inhibitors in cardiovascular-kidney-metabolic syndrome

    Durlav Chowdhury; Priyanka Dubey; Rahul Manna dkk.

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Cardiovascular-kidney-metabolic syndrome is a multifaceted condition encompassing chronic kidney disease, end-stage renal disease, and cardiovascular diseases stemming from underlying cardiometabolic disorders. Sodium-glucose co-transporter 2 inhibitors, an innovative category of hypoglycemic…

  6. Artikel Jurnal

    Effects of nemonoxacin monotherapy and nemonoxacin combined with minocycline on the prognosis in patients with non-severe

    Weihong Zhang; Miao Ma

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Objective: To analyze the effects of nemonoxacin monotherapy versus nemonoxacin combined with minocycline on the prognosis in patients with non-severe Chlamydia psittaci pneumonia (CPP). Methods: The data of 67 non-severe CPP patients who were admitted to our hospital from January 2024 to December…

  7. Artikel Jurnal

    AI-driven precision cancer treatment: Multimodal data integration and real-time decision support for personalized oncology medication

    Gayathri Krishnakumar; Karthikeyan Elumalai

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Artificial intelligence (AI) can be used to enhance precision oncology by utilizing multimodal data and real-time data provision to enhance cancer care. The analysis of digital pathology images is performed by AI, which allows for the definition of genetic traits to reduce the costs of genetic…

  8. Artikel Jurnal

    Determination of valproic acid concentration in human serum by LC-MS/MS and its application in therapeutic drug monitoring in patients with epilepsy

    Yan Yan; Di An; Weiwei Zhang dkk.

    Precision Medication, Vol. 3 No. 3 · 2026 · Inggris · DOAJ

    Background: Valproic acid (VPA), a first-line broad-spectrum antiepileptic drug, is widely used in the treatment of various types of epilepsy. It has a narrow effective therapeutic concentration range (50–100 μg·mL -1 ) and significant individual variability in pharmacokinetics. Therefore, the…

  9. Artikel Jurnal

    Pharmacokinetic/pharmacodynamic target-based dose optimization of quinolones

    Siwei Guo; Miaomei Tian; Jingji Dai dkk.

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    Quinolones are widely used for the treatment of bacterial infections because of their broad antimicrobial spectrum, favorable tissue penetration, and concentration-dependent bactericidal activity. Optimization of quinolone dosing regimens based on pharmacokinetic/pharmacodynamic (PK/PD) principles…

  10. Artikel Jurnal

    Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy

    Mohammed Khaled Al Alaili

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    Growing evidence over recent years has established a bidirectional relationship between gut dysbiosis and mental health. This paper proposes that gut microbial imbalance and related functional disturbances may represent a plausible, testable biological modifier of psychotropic treatment response…

  11. Artikel Jurnal

    Phytochemical characterization, antioxidant and immunomodulatory evaluation of C-Health Forte: An ayurvedic proprietary medicine

    Deepak M; Sulaiman C. T; Syamily Sivadas dkk.

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    Objective: C-Health Forte (CHF) is an Ayurvedic proprietary formulation designed to promote overall health, well-being and immune regulation. It comprises eleven medicinal plants widely used in Ayurveda. This study aimed at phytochemical profiling and pharmacological evaluation of CHF using…

  12. Artikel Jurnal

    Integrated analysis of tissue-exosome Co--differentially expressed genes and their role in diagnosis and pathogenesis of colon cancer

    Siming Yu; Mingjuan Wu; Le yan Zhou dkk.

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    Objective: This study aimed to systematically identify co-differentially expressed genes (co-DEGs) by integrating transcriptomic data from colon cancer tissues and circulating exosomes, and to elucidate their roles in pathogenesis and diagnostic potential. Methods: We retrieved colon cancer tissue…

  13. Artikel Jurnal

    Antihyperlipidemic and thrombolytic potential of medicinal plants: Mechanistic insights and precision medicine perspectives

    A.G. Kingre; D.D. Ghube; P.R. Tathe

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    Background: Hyperlipidemia and thrombosis are major contributors to cardiovascular morbidity and mortality worldwide. Although synthetic antihyperlipidemic and thrombolytic agents are clinically effective, their long-term use is limited by adverse effects and patient intolerance. Medicinal plants…

  14. Artikel Jurnal

    Cell-penetrating peptides as a gateway for nanocarrier-mediated glioblastoma therapy

    Aditi Sonone; Mansi Thakur; Sagar Trivedi dkk.

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    The most virulent primary brain cancer is Glioblastoma Multiforme (GBM), which is defined mainly by poor survival and drug delivery failure as a therapy. The blood-brain barrier (BBB) restricts the passage of nearly all macromolecular drugs. The presence of a heterogeneous blood-tumor barrier (BTB)…

  15. Artikel Jurnal

    A network meta-analysis of second-line immune checkpoint inhibitors and docetaxel for advanced non-small cell lung cancer: An economic evaluation from China

    Yunfeng Zhao; Fanyu Meng; Fenghao Shi dkk.

    Precision Medication, Vol. 3 No. 2 · 2026 · Inggris · DOAJ

    Background: Although previous studies have compared the economic benefits of single immune checkpoint inhibitors (ICIs) and docetaxel, few studies have conducted detailed comparisons of different ICIs within China's medical system. This study wanted to see which of the four ICIs-nivolumab…

  16. Artikel Jurnal

    Reverse MIC drift of nemonoxacin and its advantages against Gram-positive bacteria: A 10-year multicenter surveillance study

    Jie Wu; Yun Li; Bo Zheng

    Precision Medication, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Background: Antimicrobial resistance (AMR) threatens global health. Conventional fluoroquinolones have experienced accelerated resistance due to target‑enzyme mutations and are further constrained by safety concerns. Nemonoxacin, as the first non‑fluorinated quinolone, overcomes the aforementioned…

  17. Artikel Jurnal

    Integrating precision medicine and artificial intelligence to prevent cardiotoxicity in cardiovascular drug therapy

    Akrati Pathak; Tarique Anwer; Ankit Verma dkk.

    Precision Medication, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Precision medicine refers to tailoring therapeutic interventions to an individual’s genetic, molecular and phenotypic characteristics, while multi-omics integrates genomics, proteomics and metabolomics data to provide a systems-level view of disease. Together with artificial intelligence (AI)…

  18. Artikel Jurnal

    Role of nemonoxacin as a therapeutic option for community-acquired pneumonia in the era of atypical pathogens

    Xiaoping Zhang; Guoli Mo; Fengjia Zhu dkk.

    Precision Medication, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Objective: To systematically summarize the clinical data from phase II–IV studies of nemonoxacin malate and comprehensively evaluate the clinical efficacy of nemonoxacin in treating pneumonia caused by atypical pathogens, so as to inform empirical antimicrobial selection in clinical practice…

  19. Artikel Jurnal

    Expert consensus on medication therapy for acid-related diseases

    Youhong Hu

    Precision Medication, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    Acid-related diseases (ARDs) are characterized by high incidence rates and significant disease burden. Excessive gastric acid secretion or heightened gastric acid sensitivity is the common pathogenesis of these conditions, leading to the widespread application of the principle of ''treating…

  20. Artikel Jurnal

    Challenges in utilizing the FAERS database for adverse drug reaction data mining: A critical analysis

    Xuelin Sun; Yatong Zhang; Dongfang Qian

    Precision Medication, Vol. 3 No. 1 · 2026 · Inggris · DOAJ

    The FAERS database is a vital tool for identifying adverse drug reactions (ADRs). However, data mining in FAERS faces significant challenges, including data quality issues (e.g., integrity, consistency, and completeness) and limitations in traditional model selection. These issues can introduce…